Valentina Zanrè

7PUBLICATIONS
12CO-AUTHORS
Molecular targetsPredictive and prognostic markersEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 27, 2026
Onconase Induces Apoptosis in Dabrafenib-Resistant Melanoma Cell Lines Through Dysregulation of ROS Homeostasis, Antioxidant Protein Expression, and Mitochondrial Dynamics.

Carlotta Passarini, Alessia Cardile, Filippo Zuanetti

|Nov 27, 2024
BRAF-Mutated Melanoma Cell Lines Develop Distinct Molecular Signatures After Prolonged Exposure to AZ628 or Dabrafenib: Potential Benefits of the Antiretroviral Treatments Cabotegravir or Doravirine on BRAF-Inhibitor-Resistant Cells.

Valentina Zanrè, Francesco Bellinato, Alessia Cardile

|Feb 10, 2024
Lamivudine, Doravirine, and Cabotegravir Downregulate the Expression of Human Endogenous Retroviruses (HERVs), Inhibit Cell Growth, and Reduce Invasive Capability in Melanoma Cell Lines.

Valentina Zanrè, Francesco Bellinato, Alessia Cardile

|Jul 29, 2023
Hyperforin Enhances Heme Oxygenase-1 Expression Triggering Lipid Peroxidation in BRAF-Mutated Melanoma Cells and Hampers the Expression of Pro-Metastatic Markers.

Alessia Cardile, Carlotta Passarini, Valentina Zanrè

|Jan 21, 2023
Hyperforin Elicits Cytostatic/Cytotoxic Activity in Human Melanoma Cell Lines, Inhibiting Pro-Survival NF-κB, STAT3, AP1 Transcription Factors and the Expression of Functional Proteins Involved in Mitochondrial and Cytosolic Metabolism.

Alessia Cardile, Valentina Zanrè, Rachele Campagnari

|Feb 15, 2022
Upregulation of miR-34a-5p, miR-20a-3p and miR-29a-3p by Onconase in A375 Melanoma Cells Correlates with the Downregulation of Specific Onco-Proteins.

Elisa De Tomi, Rachele Campagnari, Elisa Orlandi

Pageof 2

Frequent Collaborators

7 joint publications

Marta Menegazzi

2 joint publications

Giovanni Gotte

2 joint publications

Francesco Bellinato

2 joint publications

Stefano Di Bella